Table 5.
Association between TERT, CHRNA5, and OGG1 polymorphisms and lung cancer risk, stratified by gender, age, smoking, and histological at the level of alleles.
| Population | Gene | Allele | Case/controla | p | ORAdj | CIAdj | P Adj |
|---|---|---|---|---|---|---|---|
| Smokers§ | TERT | T | 132/59 | ||||
| C | 50/19 | 0.60 | 1.15 | 0.62–2.18 | 0.66 | ||
| CHRNA5 | G | 128/82 | |||||
| A | 80/40 | 0.30 | 1.25 | 0.78–2.03 | 0.34 | ||
| OGG1 | C | 154/93 | |||||
| G | 54/29 | 0.65 | 1.07 | 0.64–1.83 | 0.79 | ||
|
| |||||||
| Nonsmokers§ | TERT | T | 55/69 | ||||
| C | 11/11 | 0.62 | 1.36 | 0.52–3.54 | 0.52 | ||
| CHRNA5 | G | 52/142 | |||||
| A | 22/58 | 0.91 | 0.98 | 0.53–1.78 | 0.95 | ||
| OGG1 | C | 54/141 | |||||
| G | 22/59 | 0.93 | 0.92 | 0.50–1.67 | 0.81 | ||
|
| |||||||
| Adenocarcinoma§§ | TERT | T | 131/128 | ||||
| C | 39/30 | 0.38 | 1.16 | 0.66–2.04 | 0.57 | ||
| CHRNA5 | G | 114/224 | |||||
| A | 74/98 | 0.04 | 1.33 | 0.89–1.98 | 0.15 | ||
| OGG1 | C | 137/234 | |||||
| G | 53/88 | 0.88 | 1.07 | 0.69–1.63 | 0.75 | ||
|
| |||||||
| Squamous§§ | TERT | T | 56/128 | ||||
| C | 22/30 | 0.11 | 1.48 | 0.71–3.08 | 0.28 | ||
| CHRNA5 | G | 66/224 | |||||
| A | 28/98 | 0.90 | 0.87 | 0.49–1.52 | 0.64 | ||
| OGG1 | C | 71/234 | |||||
| G | 23/88 | 0.58 | 0.88 | 0.48–1.60 | 0.70 | ||
|
| |||||||
| Male∗∗ | TERT | T | 146/90 | ||||
| C | 52/24 | 0.30 | 1.15 | 0.64–2.11 | 0.63 | ||
| CHRNA5 | G | 145/123 | |||||
| A | 87/57 | 0.21 | 1.21 | 0.78–1.87 | 0.38 | ||
| OGG1 | C | 175/133 | |||||
| G | 60/47 | 0.91 | 0.98 | 0.61–1.57 | 0.93 | ||
|
| |||||||
| Female∗∗ | TERT | T | 41/38 | ||||
| C | 9/6 | 0.56 | 1.45 | 0.47–4.76 | 0.51 | ||
| CHRNA5 | G | 35/101 | |||||
| A | 15/41 | 0.88 | 0.99 | 0.47–2.02 | 0.98 | ||
| OGG1 | C | 34/101 | |||||
| G | 16/41 | 0.68 | 1.07 | 0.51–2.16 | 0.85 | ||
|
| |||||||
| >60∗ | TERT | T | 92/37 | ||||
| C | 34/5 | 0.04 | 2.21 | 0.84–6.96 | 0.13 | ||
| CHRNA5 | G | 91/53 | |||||
| A | 53/27 | 0.65 | 1.12 | 0.63–2.03 | 0.69 | ||
| OGG1 | C | 105/55 | |||||
| G | 39/25 | 0.51 | 0.86 | 0.47–1.61 | 0.64 | ||
|
| |||||||
| <60∗ | TERT | T | 95/91 | ||||
| C | 27/25 | 0.91 | 0.94 | 0.49–1.79 | 0.86 | ||
| CHRNA5 | G | 89/171 | |||||
| A | 49/71 | 0.21 | 1.18 | 0.73–1.90 | 0.48 | ||
| OGG1 | C | 103/179 | |||||
| G | 37/63 | 0.93 | 1.14 | 0.68–1.89 | 0.60 | ||
OR = odds ratio; CI = confidence interval; Adj = adjusted. ∗OR and p adjusted for smoking and gender. ∗∗OR adjusted for age and smoking habit. aNumbers may not add up total number of patients due to genotype failures. §OR adjusted for gender and age. §§OR adjusted for gender, age and smoking habit.